# Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens

> **NCT05821582** · — · WITHDRAWN · sponsor: **Sanguine Biosciences**

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** Stool Collection and Survey Completion

## Key facts

- **NCT ID:** NCT05821582
- **Lead sponsor:** Sanguine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-27
- **Primary completion:** 2023-10-05
- **Final completion:** 2023-10-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient recruitment population.
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05821582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05821582, "Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05821582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*